Ibex Wealth Advisors Novo Cure LTD Transaction History
Ibex Wealth Advisors
- $902 Million
- Q2 2025
Shares
2 transactions
Others Institutions Holding NVCR
# of Institutions
284Shares Held
76.7MCall Options Held
943KPut Options Held
155K-
Black Rock Inc. New York, NY12.1MShares$156 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$138 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT6.9MShares$88.5 Million9.53% of portfolio
-
Capital World Investors Los Angeles, CA6.38MShares$81.8 Million0.02% of portfolio
-
State Street Corp Boston, MA2.68MShares$34.3 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.35B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...